Article Details
Retrieved on: 2021-10-11 14:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The experimental monoclonal antibodies therapy, called AZD7442, reduced the risk of severe COVID-19 or death by half in non-hospitalised patients who have ...
Article found on: www.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here